NY/NJ CEO offers senior-level industry leaders a unique opportunity to collaborate, build partnerships and share insights through candid panel discussions with peers.
NEW YORK (PRWEB) OCTOBER 16, 2019
LeadingBiotech, an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its NY/NJ CEO conference to be held on November 5, 2019 at Apella by Alexandria in New York, NY.
The event offers senior-level industry leaders a unique opportunity to collaborate, build partnerships and share insights through candid panel discussions with peers. C-level executives, VPs and partners can participate in forums on pressing industry issues and biopharma business development, centering on the New York biopharma ecosystem.
“The NY/NJ conference convenes executive-level biopharma leaders in this region to discuss broad industry issues as well as issues directly impacting the New York ecosystem,” said Wendy Nelson, Ph.D., CEO, LeadingBiotech.
To secure a spot at the conference, register here.
Key new topics at this year’s conference include, The New Wave of NY Biotech; Company Building: Choosing HQ, Workforce and Company Culture; Accelerating Gene Therapies to the Patient; and Issues in Board Development for Biotech CEOs.
Keynote speakers at the conference include:
- Liz Barrett, CEO, UroGen Pharma
- James Flynn, Managing Partner, Deerfield Management
- Allison Jeynes-Ellis, CEO, Avillion
- Gordana Vunjak-Novakovic, University Professor, Mikati Foundation Professor, Biomedical Engineering and Medicine Director, Laboratory for Stem Cells and Tissue Engineering, Columbia University
Other speakers include:
- Thomas Brennan, Partner, Arch Ventures
- Sammy Farah, CEO, Turnstone Biologics
- Erik Lium, Ph.D., EVP, MT Sinai Innovation Partners
- Maria Mitchell, Ph.D., SVP, Life Sciences, Empire State Development
- Gaurav Shah, President & CEO, Rocket Pharma
- Erika Smith, CEO, ReNetX Bio
- Nancy Thornberry, CEO, Kallyope
- Misti Ushio, Ph.D., CEO, TARA Biosystems
- Ben Zeskind, Ph.D., Co-Founder and CEO, Immuneering Corporation
See full agenda here.
About LeadingBiotech
Formerly known as Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We are working hard to create more valuable experiences to re-energize collaboration and infuse fresh ideas to better shape the future of biotech. For more information, please visit: https://leadingbiotech.com/.
“The NY/NJ conference convenes executive-level biopharma leaders in this region to discuss broad industry issues as well as issues directly impacting the New York ecosystem.” – Wendy Nelson, Ph.D., CEO, LeadingBiotech
